MDCG guidance
MDCG 2023-3 rev.1: Questions and Answers on vigilance terms and concepts as outlined in the Regulation (EU) 2017/745 on medical devices and Regulation (EU) 2017/746
MDCG guidance · Post-Market Surveillance and Vigilance (PMSV) · November 2024
Key facts
| Reference | MDCG 2023-3 rev.1 |
|---|---|
| Title | Questions and Answers on vigilance terms and concepts as outlined in the Regulation (EU) 2017/745 on medical devices and Regulation (EU) 2017/746 |
| Topic | Post-Market Surveillance and Vigilance (PMSV) |
| Published | November 2024 |
| Document | health.ec.europa.eu |
At a glance
- Yes Full text searchable in Orca1
- MDCG 2023-3 rev.1 (November 2024), MDCG 2023-3 (February 2023) Revisions on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About MDCG guidance documents
The Medical Device Coordination Group (MDCG), made up of EU member-state experts, endorses guidance on applying the Medical Devices Regulation (EU) 2017/745 and the In Vitro Diagnostic Regulation (EU) 2017/746. Each page here covers one document and all of its revisions.